Uncontrolled Postviral Asthma and Persistent Symptoms After COVID-19

Uncontrolled Postviral Asthma in Patients With Long Covid

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05919004

Acronym

COVID-19

Enrollment

Registered

2023-06-26

Start date

2022-05-01

Completion date

2022-12-31

Last updated

2023-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long COVID

Keywords

postviral asthma, diagnosis, long covid, telemedicine, lung function, digital spirometer

Brief summary

Patients with long covid referred for physical rehabilitation at the Norwegian Sports Medicine Centre - Football Association in Oslo, Norway, were assessed for postviral asthma.

Detailed description

All patients performed methacholin bronchial provocation test, and those with a negative bronchial provocation were eqipped with an app-based spirometer to detect excessive lung variability. Eventual detection of postviral asthma will be treated according to GINA guidelines and eventual effect will be assessed by lung function variability and symptoms.

Interventions

DIAGNOSTIC_TESTApp-based spirometer

App-based spirometer to perform serial spirometry to assess lung function variatione

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Inclusion criteria

° Patients with long covid for more than 6 months referred for physical rehabilitation

Exclusion criteria

° None

Design outcomes

Primary

Measure	Time frame	Description
Perceived symptoms of long covid	8 months	On a Likert scale 1-10
Excessive lung function variation	8 months	Lung function given as FEV1.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026